• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Squarespace Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session

    6/16/23 1:08:12 PM ET
    $ADBE
    $ADRT
    $APPH
    $ATIP
    Computer Software: Prepackaged Software
    Technology
    Blank Checks
    Finance
    Get the next $ADBE alert in real time by email

    Gainers

    • Oncorus, Inc. (NASDAQ:ONCR) shares surged 258% to $0.2781.
    • Evelo Biosciences, Inc. (NASDAQ:EVLO) shares jumped 216.2% to $0.2622 after the company won U.S. Patent for prebiotic compositions and methods of use thereof for modulation of the microbiome.
    • Navidea Biopharmaceuticals, Inc. (NASDAQ:NAVB) gained 58% to $0.1296. Navidea Biopharmaceutical recently posted a narrower first-quarter loss.
    • Virgin Galactic Holdings, Inc. (NYSE:SPCE) shares climbed 32.1% to $5.36 as the company announced the start of commercial spaceline operations. The company said its first commercial spaceflight, "Galactic 01," is set to fly between June 27 and June 30.
    • Plutonian Acquisition Corp. (NASDAQ:PLTNR) shares surged 24.2% to $0.41 after jumping 32% on Thursday.
    • Microbot Medical Inc. (NASDAQ:MBOT) rose 21.7% to $3.48. Microbot Medical announced multiple peer reviewed abstracts accepted by the Cardiovascular and Interventional Radiological Society of Europe.
    • VCI Global Limited (NASDAQ:VCIG) gained 20.2% to $2.91 after it announced a partnership with Fusionex to provide Artificial Intelligence and Big Data Services to clients.
    • iRobot Corporation (NASDAQ:IRBT) shares climbed 19.2% to $50.15 after UK's Competition and Markets Authority cleared its acquisition deal with Amazon.
    • NeuBase Therapeutics, Inc. (NASDAQ:NBSE) gained 17% to $3.2295. NeuBase Therapeutics recently announced a 1-for-20 reverse stock split.
    • Humanigen, Inc. (NASDAQ:HGEN) shares rose 16.2% to $0.1866. Humanigen recently presented promising new hematologic data from PREACH-M trial for chronic myelomonocytic leukemia treatment at the 2023 European Hematology Association Congress.
    • INVO Bioscience, Inc. (NASDAQ:INVO) gained 15.4% to $0.1960.
    • SmileDirectClub, Inc. (NASDAQ:SDC) climbed 15% to $0.4950.
    • AppHarvest, Inc. (NASDAQ:APPH) gained 14.1% to $0.4599.
    • OpGen, Inc. (NASDAQ:OPGN) shares climbed 13.9% to $0.6950. OpGen, last month, posted a wider-than-expected quarterly loss.
    • Ault Disruptive Technologies Corporation (NYSE:ADRT) shares gained 13.8% to $12.40.
    • Lordstown Motors Corp. (NASDAQ:RIDE) gained 13.3% to $4.7683..
    • Cohen & Company Inc. (NYSE:COHN) rose 13.3% to $5.11.
    • TMC the metals company Inc. (NASDAQ:TMC) surged 11.6% to $1.23.
    • Ontrak, Inc. (NASDAQ:OTRK) gained 10.8% to $0.6095.
    • FingerMotion, Inc. (NASDAQ:FNGR) shares gained 10.8% to $2.25 after climbing over 18% on Thursday.
    • Nikola Corporation (NASDAQ:NKLA) gained 8.6% to $1.52 after gaining around 30% on Thursday. The EV maker also gained last week after shareholders reportedly rejected the company's proposal to issue more stock shares.
    • Community Health Systems, Inc. (NYSE:CYH) rose 8.3% to $4.4185.
    • Eneti Inc. (NYSE:NETI) gained 8.2% to $12.68 after the company and Cadeler A/S announced they have entered into a business combination agreement to combine through a stock-for-stock exchange.
    • COMSovereign Holding Corp. (NASDAQ:COMS) gained 8.1% to $2.00.
    • Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) rose 7.5% to $0.1930. MEI Pharma and Infinity Pharmaceuticals, said that the companies will host a recorded joint video webcast that will be available at 8:00 am Eastern Time on June 19, 2023.
    • Squarespace, Inc. (NYSE:SQSP) shares rose 7.2% to $33.64 after the company announced it entered into a definitive agreement to acquire Google Domains assets.
    • NaaS Technology Inc. (NASDAQ:NAAS) gained 6.8% to $6.60 following quarterly results.
    • MorphoSys AG (NASDAQ:MOR) rose 6.5% to $7.57. JP Morgan upgraded MorphoSys from Underweight to Overweight and raised the price target from $3.3 to $10.
    • Adobe Inc. (NASDAQ:ADBE) shares gained 2.2% to $501.63 as the company reported better-than-expected results for its second quarter and issued strong earnings forecast.

    Losers

    • Panbela Therapeutics, Inc. (NASDAQ:PBLA) shares fell 52.5% to $2.76 after the company announced pricing of an approximately $8.5 million public offering,
    • Applied UV, Inc. (NASDAQ:AUVI) fell 42.1% to $1.10. Applied UV retained Quantiva to integrate AI and machine learning capabilities into its PURONetaAnd Airocide Systems.
    • Universe Pharmaceuticals INC (NASDAQ:UPC) dropped 30.1% to $0.58.
    • EdtechX Holdings Acquisition Corp. II (NASDAQ:EDTX) shares dropped 20.5% to $26.89 after jumping 207% on Thursday. The company announced Wednesday an amendment to extend the date to consummate a business combination from June 15, 2023 to Dec. 15, 2023.
    • Clene Inc. (NASDAQ:CLNN) fell 19.1% to $0.85 after the company announced pricing of a $40 million public offering. Clene’s CNM-Au8 treatment demonstrated a statistically significant reduction of plasma neurofilament light chain levels compared to placebo at 24 weeks.
    • Coherus BioSciences, Inc. (NASDAQ:CHRS) fell 16.8% to $4.48. Coherus BioSciences agreed to acquire Surface Oncology Inc (NASDAQ:SURF), a clinical-stage immuno-oncology (I-O) company developing next-generation immunotherapies that target the tumor microenvironment.
    • Jeffs' Brands Ltd (NASDAQ:JFBR) dropped 16.5% to $0.9101.
    • Stereotaxis, Inc. (NYSE:STXS) fell 14.5% to $1.7275. Stereotaxis will initiate first-in-human trial to support CE Mark application of MAGiC Catheter.
    • Leju Holdings Limited (NYSE:LEJU) shares dropped 14.1% to $3.2897 after gaining 31% on Thursday.
    • AEye, Inc. (NASDAQ:LIDR) fell 13.6% to $0.1988.
    • ATI Physical Therapy, Inc. (NYSE:ATIP) dropped 13.5% to $8.83. ATI Physical Therapy completed transaction support agreement to increase liquidity and financial flexibility.
    • VIQ Solutions Inc. (NASDAQ:VQS) shares fell 13.5% to $0.3009. VIQ Solutions shares gained 32% on Thursday after the company partnered Justice AV Solutions to bring AI-generated draft transcripts of courtroom proceedings.
    • Healthcare Triangle, Inc. (NASDAQ:HCTI) dropped 13.4% to $2.83.
    • Cabot Corporation (NYSE:CBT) fell 10.4% to $66.83 after the company disclosed the impact of the current demand environment on its business segments.
    • Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) fell 10.1% to $5.10 after jumping around 25% on Thursday. The company recently reported a $2 million buyback program.
    • Axcella Health Inc. (NASDAQ:AXLA) dropped 9.9% to $0.2821.
    • MicroVision, Inc. (NASDAQ:MVIS) fell 9.4% to $4.5750. Microvision said it entered into sales agreement with Craig-Hallum Capital Group relating to sale of up to $45 million of company’s common stock.
    • Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) fell 8.2% to $8.34.
    • Tenon Medical, Inc. (NASDAQ:TNON) fell 7.9% to $0.3009 after adding 16% on Thursday. Tenon Medical recently priced its public offering of $5.6M at $0.56 per unit.
    • ZoomInfo Technologies Inc. (NASDAQ:ZI) dropped 7.5% to $26.27.

     

    Now Read This: Bitcoin Surpasses This Key Level; Trust Wallet Token Emerges As Top Gainer

    Get the next $ADBE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADBE
    $ADRT
    $APPH
    $ATIP

    CompanyDatePrice TargetRatingAnalyst
    Adobe Inc.
    $ADBE
    4/13/2026Neutral
    BTIG Research
    Olema Pharmaceuticals Inc.
    $OLMA
    3/27/2026Peer Perform
    Wolfe Research
    Adobe Inc.
    $ADBE
    3/26/2026Mkt Perform
    William Blair
    Olema Pharmaceuticals Inc.
    $OLMA
    3/19/2026Buy
    Jefferies
    Adobe Inc.
    $ADBE
    3/16/2026Buy → Hold
    Argus
    Adobe Inc.
    $ADBE
    3/13/2026$275.00Overweight → Equal Weight
    Barclays
    Adobe Inc.
    $ADBE
    3/13/2026$375.00 → $285.00Market Perform
    BMO Capital Markets
    Olema Pharmaceuticals Inc.
    $OLMA
    2/11/2026$48.00Buy
    Stifel
    More analyst ratings

    $ADBE
    $ADRT
    $APPH
    $ATIP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Matlin David J bought $216,664 worth of shares (33,333 units at $6.50), increasing direct ownership by 7% to 477,824 units (SEC Form 4)

    4 - Clene Inc. (0001822791) (Issuer)

    1/13/26 2:48:54 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Leong Yew Poh decreased direct ownership by 6% to 160,000 units (SEC Form 4)

    4 - FingerMotion, Inc. (0001602409) (Issuer)

    12/29/25 6:26:12 AM ET
    $FNGR
    Computer Software: Prepackaged Software
    Technology

    Director Leong Yew Poh decreased direct ownership by 6% to 170,000 units (SEC Form 4)

    4 - FingerMotion, Inc. (0001602409) (Issuer)

    12/8/25 7:08:12 AM ET
    $FNGR
    Computer Software: Prepackaged Software
    Technology

    $ADBE
    $ADRT
    $APPH
    $ATIP
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for CIMERLI issued to COHERUS BIOSCIENCES INC

    Submission status for COHERUS BIOSCIENCES INC's drug CIMERLI (SUPPL-5) with active ingredient RANIBIZUMAB-EQRN has changed to 'Approval' on 05/21/2024. Application Category: BLA, Application Number: 761165, Application Classification:

    5/22/24 9:41:01 AM ET
    $CHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for LOQTORZI issued to COHERUS BIOSCIENCES INC

    Submission status for COHERUS BIOSCIENCES INC's drug LOQTORZI (SUPPL-1) with active ingredient TORIPALIMAB-TPZI has changed to 'Approval' on 04/22/2024. Application Category: BLA, Application Number: 761240, Application Classification:

    4/23/24 4:41:07 AM ET
    $CHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for UDENYCA issued to COHERUS BIOSCIENCES INC

    Submission status for COHERUS BIOSCIENCES INC's drug UDENYCA (SUPPL-15) with active ingredient PEGFILGRASTIM-CBQV has changed to 'Approval' on 12/22/2023. Application Category: BLA, Application Number: 761039, Application Classification:

    12/27/23 4:38:39 AM ET
    $CHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADBE
    $ADRT
    $APPH
    $ATIP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BTIG Research initiated coverage on Adobe

    BTIG Research initiated coverage of Adobe with a rating of Neutral

    4/13/26 8:51:07 AM ET
    $ADBE
    Computer Software: Prepackaged Software
    Technology

    Wolfe Research initiated coverage on Olema Pharmaceuticals

    Wolfe Research initiated coverage of Olema Pharmaceuticals with a rating of Peer Perform

    3/27/26 8:52:12 AM ET
    $OLMA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    William Blair resumed coverage on Adobe

    William Blair resumed coverage of Adobe with a rating of Mkt Perform

    3/26/26 8:44:26 AM ET
    $ADBE
    Computer Software: Prepackaged Software
    Technology

    $ADBE
    $ADRT
    $APPH
    $ATIP
    SEC Filings

    View All

    SEC Form 8-K filed by Community Health Systems Inc.

    8-K - COMMUNITY HEALTH SYSTEMS INC (0001108109) (Filer)

    4/22/26 8:20:46 PM ET
    $CYH
    Hospital/Nursing Management
    Health Care

    SEC Form 10-Q filed by Community Health Systems Inc.

    10-Q - COMMUNITY HEALTH SYSTEMS INC (0001108109) (Filer)

    4/22/26 4:30:41 PM ET
    $CYH
    Hospital/Nursing Management
    Health Care

    Microbot Medical Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Microbot Medical Inc. (0000883975) (Filer)

    4/22/26 8:30:29 AM ET
    $MBOT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADBE
    $ADRT
    $APPH
    $ATIP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AEye Announces New VP of Operations and Quality and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

    AEye, Inc. (NASDAQ:LIDR), a global leader in software-defined, high-performance lidar solutions, today announced the grant of an inducement equity award to its newly appointed Vice President Operations and Quality, Paul Berton. The grant was approved by the Compensation Committee of the Company's Board of Directors as a material inducement to Mr. Berton entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). Mr. Berton received, as an inducement to accept employment, an incentive award of 125,000 restricted stock units (the "RSUs"). These RSUs will vest as follows: one-third of the total grant is expected to vest on May 15, 2027, and the remainder of t

    4/23/26 4:00:00 PM ET
    $LIDR
    Auto Parts:O.E.M.
    Consumer Discretionary

    Healthcare Triangle, Inc. Launches AI-Driven Digital Self-Care Therapy Platform "ZoraNex" to address the $450B Global Mental Health Market

    Positioning this new platform at the intersection of AI, healthcare delivery, and preventive wellness for Its Global Healthcare Expansion StrategyPLEASANTON, Calif., April 23, 2026 /CNW/ -- Healthcare Triangle, Inc. (NASDAQ:HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions for healthcare and life sciences, today announced the launch of ZoraNex, an AI-driven digital self-care therapy platform developed under its wholly owned subsidiary, QuantumNexis Inc ("QuantumNexis"). The launch represents a key milestone in the Company's broader strategy to build a scalable, AI-powered healthcare ecosystem across global markets, with a particular focus on Southeast Asia as a co

    4/23/26 8:05:00 AM ET
    $HCTI
    EDP Services
    Technology

    Senmiao Technology Appoints David Nichols as Strategic Advisor to Advance AI Data Center, Digital Infrastructure, and New Energy Strategy

    Veteran Infrastructure Finance and Carbon Markets Executive Brings Public Company Leadership, Hyperscale Data Center Development, and Capital Markets Structuring Expertise to AIHS Growth Platform Chengdu, China, April 23, 2026 (GLOBE NEWSWIRE) -- Senmiao Technology Limited ("Senmiao" or the "Company") (NASDAQ:AIHS) today announced the appointment of David Nichols as Strategic Advisor, effective immediately. In this role, Mr. Nichols will drive the Company's business development and strategic execution across its AI data center solutions, digital infrastructure, and new energy initiatives, with a particular focus on power infrastructure origination, capital formation, and institutional pa

    4/23/26 8:00:00 AM ET
    $AIHS
    $APPH
    Finance: Consumer Services
    Finance
    Farming/Seeds/Milling
    Consumer Staples

    $ADBE
    $ADRT
    $APPH
    $ATIP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Shen Martin Chung-Wen

    4 - FingerMotion, Inc. (0001602409) (Issuer)

    4/23/26 9:16:36 AM ET
    $FNGR
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Ugwumba Chidozie

    4 - Clene Inc. (0001822791) (Issuer)

    4/22/26 5:55:36 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Krishnan K Ranga

    4 - COMMUNITY HEALTH SYSTEMS INC (0001108109) (Issuer)

    4/22/26 4:47:18 PM ET
    $CYH
    Hospital/Nursing Management
    Health Care

    $ADBE
    $ADRT
    $APPH
    $ATIP
    Leadership Updates

    Live Leadership Updates

    View All

    Critical Minerals Boom: Nickel–Cobalt Market Races Toward $35B+ Valuation

    NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - Nickel–cobalt alloys might not sound exciting at first, but they're actually a big deal in modern defense. These materials are used in things like jet engines, missile systems, and naval equipment because they can handle extreme heat and stress without breaking down. That's why governments are starting to treat nickel and cobalt as must-have resources, not just commodities. There's also a growing push to secure supply closer to home, since a lot of global production is concentrated in a few regions—something that makes defense planners (and investors) a bit uneasy.   Active Companies mentioned in the article

    3/31/26 8:45:00 AM ET
    $ALOY
    $MP
    $TMC
    EDP Services
    Technology
    Metal Mining
    Basic Materials

    Virgin Galactic Appoints Megan Prichard as Chief Growth Officer

    Veteran technology leader and former Uber executive to drive revenue growth, market expansion and customer acquisition for human spaceflight and research missions Virgin Galactic Holdings, Inc. (NYSE:SPCE) ("Virgin Galactic" or the "Company"), a leader in commercial spaceflight and advanced aerospace technology, today announced the appointment of Megan Prichard as its new Chief Growth Officer (CGO), effective April 6. In this newly established role, Prichard will lead the Company's integrated growth and revenue strategy across all business lines while strengthening Virgin Galactic's position as the premier platform for suborbital spaceflight expeditions and scientific research. Prichard

    3/23/26 4:05:00 PM ET
    $BL
    $SPCE
    Computer Software: Prepackaged Software
    Technology
    Transportation Services
    Consumer Discretionary

    Cohen & Company Announces Appointment of Pawel Skonieczka as Managing Director to Lead Coverage of Space Technology, Aerospace, & Communications Infrastructure in Capital Markets Segment

    NEW YORK, Feb. 26, 2026 /PRNewswire/ -- After nearly doubling deal flow and closing $43 billion in transactions in 2025, Cohen & Company Capital Markets ("CCM"), a division of Cohen & Company Securities, LLC, an indirect, controlled subsidiary of Cohen & Company Inc. (NYSE:COHN), announced the appointment of Pawel Skonieczka as a Managing Director to lead the expansion of the firm's advisory capabilities across Space Technology, Aerospace, and Communications Infrastructure. Mr. Skonieczka brings nearly two decades of experience advising public and private companies, financial sp

    2/26/26 10:43:00 AM ET
    $COHN
    Investment Bankers/Brokers/Service
    Finance

    $ADBE
    $ADRT
    $APPH
    $ATIP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by ATI Physical Therapy Inc.

    SC 13D/A - ATI Physical Therapy, Inc. (0001815849) (Subject)

    12/17/24 5:51:04 PM ET
    $ATIP
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G filed by Olema Pharmaceuticals Inc.

    SC 13G - Olema Pharmaceuticals, Inc. (0001750284) (Subject)

    12/11/24 4:30:15 PM ET
    $OLMA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by VCI Global Limited

    SC 13G - VCI Global Ltd (0001930510) (Subject)

    12/6/24 6:01:22 AM ET
    $VCIG
    Diversified Commercial Services
    Consumer Discretionary

    $ADBE
    $ADRT
    $APPH
    $ATIP
    Financials

    Live finance-specific insights

    View All

    AEye to Report 2026 First Quarter Results on Wednesday, May 13 and Host Conference Call and Webcast

    AEye, Inc. (NASDAQ:LIDR), a global leader in software-defined, high-performance lidar solutions, today announced that it will release its 2026 first quarter financial results after market close on Wednesday, May 13, 2026. A conference call and webcast will be held on the same day, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time). During the call, AEye CEO Matt Fisch and CFO Conor Tierney will review the company's financial results and provide a business update, followed by a question-and-answer session. Supplemental financial information will be available on the company's website prior to the conference call. The live webcast of the call with an accompanying slide presentation can be

    4/22/26 8:00:00 AM ET
    $LIDR
    Auto Parts:O.E.M.
    Consumer Discretionary

    Community Health Systems, Inc. Announces First Quarter Ended March 31, 2026 Results

    Community Health Systems, Inc. (NYSE:CYH) (the "Company") today announced financial and operating results for the three months ended March 31, 2026. The following highlights the financial and operating results for the three months ended March 31, 2026. Net operating revenues totaled $2.965 billion. Net loss attributable to Community Health Systems, Inc. stockholders was $(58) million, or $(0.43) per share (diluted), compared to $(13) million, or $(0.10) per share (diluted), for the same period in 2025. Excluding the adjusting items as presented in the table in footnote (e) on page 12, net loss attributable to Community Health Systems, Inc. stockholders was $(0.48) per share (diluted

    4/21/26 4:15:00 PM ET
    $CYH
    Hospital/Nursing Management
    Health Care

    Stereotaxis to Report First Quarter 2026 Financial Results on May 12, 2026

    ST. LOUIS, April 21, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2026 first quarter on Tuesday, May 12, 2026 at the close of the U.S. financial markets. The Company will host a conference call and webcast at 4:30 p.m. EST that day to discuss the Company's results and corporate developments. What: Stereotaxis first quarter 2026 financial results conference call   When: Tuesday, May 12, 2026, at 4:30 p.m. ET (1:30 p.m. PT)   Dial In Number: To access the live call, dial 800-715-9871 (US and Canada) or 1-646-307-1963 (Internati

    4/21/26 9:01:00 AM ET
    $STXS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care